These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis. Dong F, Zhou X, Li C, Yan S, Deng X, Cao Z, Li L, Tang B, Allen TD, Liu J. Cancer Biol Ther; 2014 Aug 01; 15(11):1479-88. PubMed ID: 25482945 [Abstract] [Full Text] [Related]
10. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk. Beloglazova I, Stepanova V, Zubkova E, Dergilev K, Koptelova N, Tyurin-Kuzmin PA, Dyikanov D, Plekhanova O, Cines DB, Mazar AP, Parfyonova Y. Biochim Biophys Acta Mol Cell Res; 2022 Jan 01; 1869(1):119157. PubMed ID: 34619163 [Abstract] [Full Text] [Related]
11. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain. Kim KS, Hong YK, Lee Y, Shin JY, Chang SI, Chung SI, Joe Y. Exp Mol Med; 2003 Dec 31; 35(6):578-85. PubMed ID: 14749538 [Abstract] [Full Text] [Related]
20. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Takeda N, Maemura K, Imai Y, Harada T, Kawanami D, Nojiri T, Manabe I, Nagai R. Circ Res; 2004 Jul 23; 95(2):146-53. PubMed ID: 15192019 [Abstract] [Full Text] [Related] Page: [Next] [New Search]